These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 7712460)
1. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Knapek DF; Serrano M; Beach D; Trono D; Walker CL Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines. Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486 [TBL] [Abstract][Full Text] [Related]
3. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient. Glendening JM; Flores JF; Walker GJ; Stone S; Albino AP; Fountain JW Cancer Res; 1995 Dec; 55(23):5531-5. PubMed ID: 7585628 [TBL] [Abstract][Full Text] [Related]
4. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400 [TBL] [Abstract][Full Text] [Related]
5. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors. Zariwala M; Xiong Y Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552 [TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
7. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Herman JG; Jen J; Merlo A; Baylin SB Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003 [TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
9. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361 [TBL] [Abstract][Full Text] [Related]
10. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
11. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors. Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215 [TBL] [Abstract][Full Text] [Related]
12. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
13. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759 [TBL] [Abstract][Full Text] [Related]
14. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the p15, p16,and p18 genes in osteosarcoma. Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340 [TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
19. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567 [TBL] [Abstract][Full Text] [Related]
20. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]